This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Surgical Physiology, Other  • Prognosis/ Outcomes  • Alert me on articles by topic

Christine S. Cocanour, MD, FACS, FCCM

Arch Surg. 2005;140:669.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The study by Rady et al of mortality in relation to random levels and maximal increments of total cortisol, organ failure, and sex in critically ill patients illustrates the necessity of better identifying subgroups of critically ill patients who will benefit from corticosteroid supplementation. Because of the study’s observational nature, it is difficult to extrapolate further conclusions.

They found no difference in overall mortality between patients who did and did not receive corticosteroids. This is in contrast to the landmark study by Annane et al¹ that reported a significant improvement in mortality in randomized nonresponder patients. That study included only patients with severe sepsis, while Rady et al additionally included patients with circulatory failure secondary to systemic inflammatory response syndrome.

More interesting was the observation made by Rady et al of differences in mortality between sexes in nonresponders. Although this observation may be related . . . [Full Text of this Article]

AUTHOR INFORMATION

RELATED ARTICLE

Cortisol Levels and Corticosteroid Administration Fail to Predict Mortality in Critical Illness: The Confounding Effects of Organ Dysfunction and Sex
Mohamed Y. Rady, Daniel J. Johnson, Bhavesh Patel, Joel Larson, and Richard Helmers
Arch Surg. 2005;140(7):661-668.
ABSTRACT | FULL TEXT